Regulation and function of Growth Differentiation Factor 11 during development and aging

生长分化因子11在发育和衰老过程中的调节和功能

• 批准号: 9105913
• 负责人: AMY JO WAGERS
• 金额: $ 53.81万
• 依托单位: HARVARD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-04-15 至 2021-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9105913
• 关键词: Adolescent; Adult; Age; Age Factors; Aging; Animals; Biology of Aging; Blood; Body Composition; Brain; Caloric Restriction; Cardiac; Cell Count; Cells; Data; Detection; Development; Developmental Biology; Elderly; Embryonic Development; Enzyme-Linked Immunosorbent Assay; Excision; Exhibits; Exposure to; Frequencies; Functional disorder; GDF11 gene; Genetic Models; Growth; Heart; Homeostasis; Hormones; Human; Immunoassay; Individual; Injury; Knock-in; Laboratories; Lead; Life; Longevity; Maintenance; Manuscripts; Mediating; Messenger RNA; Morbidity - disease rate; Mus; Muscle; Muscle Development; Muscle Fibers; Muscle function; Muscle satellite cell; Muscular Dystrophies; Myopathy; Natural regeneration; Neonatal; Organ; Parabiosis; Pathology; Pathway interactions; Patients; Performance; Peripheral; Phenotype; Physical Function; Physiology; Play; Population; Process; Production; Proteins; Publishing; Quality of life; Recombinant Proteins; Recovery; Regulation; Reporter; Rest; Role; Serum; Signal Transduction; Skeletal Muscle; Source; Staging; Supplementation; System; Testing; Therapeutic; Time; Tissues; Transgenic Organisms; Work; Youth; age related; aged; base; bone morphogenic protein; cell type; cohort; experience; fetal; improved; in vivo; injured; insight; mRNA Expression; mature animal; middle age; mortality; muscle aging; muscle form; muscle strength; myogenesis; novel; novel strategies; pleiotropism; premature; public health relevance; regenerative; repaired; research study; restoration; sarcopenia; satellite cell; small molecule; young adult

 DESCRIPTION (provided by applicant): Healthy skeletal muscle is essential to sustain normal physical function, and muscle undergoes multiple developmental and functional transitions during fetal, neonatal and adult life. In the latest stages of life, impaired muscle homeostasis and reduced muscle regenerative potential lead to progressive loss of muscle mass and strength. Importantly, reduced muscle function in elderly individuals is one of the strongest predictors of imminent mortality, suggesting that improved understanding of the fundamental mechanisms underlying muscle aging and the development of novel strategies to intervene in this process, would have tremendous impact on lifespan and quality of life of the growing population of aged individuals experiencing degenerative muscle decline. This project is aimed at increasing our understanding of skeletal muscle function throughout life by focusing on a novel circulating hormone called Growth Differentiation Factor 11 (GDF11, also known as Bone Morphogenic Protein 11, or BMP11). Extensive published and preliminary data indicate that GDF11 plays a key role in modulating the homeostatic remodeling of skeletal muscle fibers and the regenerative activity of muscle stem cells (satellite cells) at particular stages of life. GDF1 protein circulates at high levels in neonatal and young adult animals (including humans), but declines dramatically with advancing age and in concert with the emergence of multiple age-associated pathologies in muscle and other tissues. Data from our recently published manuscripts indicate that raising the levels of circulating GDF11 in aged mice can reverse certain age-related pathologies, including recovery of satellite cell numbers in resting muscle and restoration of muscle regenerative potential after mild muscle injury. However, overproduction of this protein in younger mice subjected to severe muscle damage may have a detrimental effect. In this project, we will answer questions crucial to understanding the regulation and activity of this new candidate rejuvenating factor for aged muscle, and its potential for regulating developmental and aging phenotypes in mice and humans by: (1) defining the cellular source(s) of GDF11 throughout life and clarifying the basis for the age-dependent decline of this hormone and its potential age- and injury-dependent effects on muscle repair, (2) evaluating the impact on development and homeostasis of removal of GDF11 at discrete stages of life or in discrete GDF11- producer cells, and (3) assessing age-regulated changes in GDF11 abundance and function in human sera and correlating these with muscle performance, body composition and overall physical function in individuals with or without mobility limitations. Together, these studies will provide critical insights into muscle developmental biology and aging and may validate a promising new candidate therapeutic for the reversal of age-related skeletal muscle dysfunction.